Default mode network static-dynamic functional signatures in first-episode drug-naive major depressive disorder

Xiaoyun Liu1, Kaimo Ding2, Fan Li3

  • 1Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, China.

Insights

This study reveals altered brain network function in first-episode drug-naive major depressive disorder (MDD). Key findings show changes in the default mode network (DMN) and its connection to symptom severity.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Major Depressive Disorder (MDD) is a prevalent mood disorder.
  • The default mode network (DMN) plays a crucial role in self-referential processing and is implicated in MDD.
  • Understanding DMN alterations in early-stage MDD is vital for targeted interventions.

Purpose of the Study:

  • To investigate the static and dynamic functional alterations of the DMN in first-episode drug-naive MDD (FEDN).
  • To explore the relationship between DMN functional changes and depressive symptom severity.

Main Methods:

  • Utilized resting-state functional magnetic resonance imaging (fMRI) to assess DMN function.
  • Analyzed functional connectivity (FC) and temporal variability (TV) within the DMN.
  • Correlated neuroimaging findings with Hamilton Depression Rating Scale (HAMD-24) scores.

Main Results:

  • Significantly increased temporal variability (TV) of the dorsomedial prefrontal cortex (dMPFC) in FEDN.
  • Decreased static functional connectivity (sFC) within the DMN in both FEDN and recurrent MDD (rMDD).
  • Positive association between dMPFC TV and HAMD-24 scores in FEDN.

Conclusions:

  • Findings suggest disorder-specific abnormal functional patterns in the DMN of FEDN.
  • Highlights the potential of dynamic neural communication as a biomarker for MDD.
  • Offers a new perspective for understanding and researching fluctuating neural dynamics in early-stage depression.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
377
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
225
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
792
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
617
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
214